connect with us
For further information please fill the details below:
Skip to main content

ANNOUNCEMENT

M.Pharm+MBA Orientation scheduleLC-MS/MS facility at the SPPSPTMReport on International Conference on Artificial Intelligence in Health Care (IC. AIHC)

TOP NEWS

sppsptm-internation-yoga-news-2017

Report on International Yoga Day Celebration 

training-3-days-lc-ms-news-2017

Three days workshop and hands on training on LC-MS/MS

camtechx-jugaadathon news nmims

Runners Up at the CAMTechX Jugaadathon

best-placement-brochure-award-2016

Best Placement Brochure Award 

Dr. Pravin K. Shende

Dr. Pravin K. Shende

Associate Professor

M. Pharm., Ph.D. Post-Doctoral Fellow, Unito, Italy

Specialization

Pharmaceutics

Email Id

pravin.shende@nmims.edu

Phone No.

+91-022-42332000 (Extn- 2036)

Experience

11.5 years (Industry and Research –05 years, Academics-6.5 years)

Interest areas: 

  • Liposomes, dendrimers, SLN, resealed erythrocytes etc
  • Polyemeric nanoparticles, nanosponges, CNP, MNP, nanocrystals
  • Targeted, Transdermal, buccal, pulmonary and pulsatile drug delivery systems
  • Inclusion complexation for improving solubility and bioavailability
  • Preformulation and stability studies of conventional dosage forms

Research

  • Publications – 17 (International-11, National- 06)
  • Books- 01 (International)
  • Patents- 03 (International-01, National- 02)
  • Presentations- 14 (International- 08 , National-06)

Conferences/Workshops/Seminars attended

14

Academic activities

He has guided 10 M.Pharm. students for their research

Recent Publications

  1. Pravin Shende, Yogesh A. Kulkarni, R. S. Gaud, Kiran Deshmukh, Roberta Cavalli, Francesco Trotta and Fabrizio Caldera (2015). Acute and Repeated Dose Toxicity Studies of Different β-cyclodextrin based Nanosponge Formulations. Journal of Pharmaceutical Science, 104 1856–1863. (IF=3.09)
  2. Pravin Shende, Kiran Deshmukh, Fransesco Trotta, Fabrizio Caldera (2013). Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia. International Journal of Pharmaceutics 456 95–100. (IF=4.090)
Connect With Us x